New Malaria Vaccine Proven Effective in Phase 3 Study

Source link :

A new malaria vaccine has protected children under the age of 1.5 years against infection with an efficacy of 68%-75% in a phase 3 study. The highest level of vaccine protection was observed in areas with seasonal malaria. The new vaccine’s efficacy is similar to that of the already approved vaccine and could help meet […]

Author : News Health

Publish date : 2024-02-12 09:09:20

Copyright for syndicated content belongs to the linked Source.